Back to News
Market Impact: 0.15

Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates

STXS
Corporate EarningsCompany FundamentalsAnalyst EstimatesHealthcare & Biotech

Stereotaxis reported a Q loss of $0.06 per share, in line with the Zacks consensus, versus a $0.09 loss a year ago (a ~33% narrowing of the per‑share loss). Meeting estimates suggests limited immediate market impact and provides a modest improvement in company fundamentals versus the prior year.

Analysis

Stereotaxis reported a Q loss of $0.06 per share, in line with the Zacks consensus, versus a $0.09 loss a year ago (a ~33% narrowing of the per‑share loss). Meeting estimates suggests limited immediate market impact and provides a modest improvement in company fundamentals versus the prior year.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

neutral

Sentiment Score

0.00

Ticker Sentiment

STXS0.00